Estimated time to complete session: 75 mins.
Upon completion of this session, you should be able to:
1. Outline evidence-based pharmacologic treatment options recommended for use in pediatric patients.
2. Develop an individualized plan of care involving shared-decision making that includes monitoring for potential adverse events and overall efficacy of therapy.
3. Discuss potential barriers to therapy adherence with patients and families to identify strategies to aid in successful treatment.
4. Educate patients on the evidence surrounding efficacy and safety of herbal therapies in the management of ADHD symptoms.
View technical requirements (opens in a new window).
View CME credit information (opens in a new window).
View disclosures and disclaimers (opens in a new window).
All materials herein are protected by copyright and are for the sole, personal use of the purchaser. No part of the written, oral, and broadcast production may be copied, duplicated, replicated or retransmitted without the prior permission of the applicable copyright owner.
The unauthorized reproduction or distribution of a copyrighted work is illegal. Criminal copyright infringement, including infringement without monetary gain, is investigated by the FBI and is punishable by up to five years in federal prison and a fine of $250,000.
Robin K. Blitz, MD – Senior Medical Director, Special Needs Initiative of United Healthcare, Clinical Associate Professor, University of Arizona College of Medicine, Phoenix
- 1.25 AAFP prescribed